Depakote
Divalproex Sodium
- Strength
- 250 mg/1
- Form
- Tablet, Delayed Release
- Class
- Anti-epileptic Agent; Mood Stabilizer
AbbVie Inc.
Listed by Upsher-Smith Laboratories, LLC
| Dosage form | Tablet, Delayed Release |
|---|---|
| Route | Oral |
| Drug class | Anti-epileptic Agent; Mood Stabilizer |
| Approval route | ANDA — approved generic |
| NDC code | 0832-7124 |
| FDA application | ANDA078182 |
| RxNorm concept | 1099625 |
| Package sizes listed | 3 |
| Marketed since | March 2014 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Divalproex Sodium
AbbVie Inc.
Divalproex Sodium
AbbVie Inc.
Divalproex Sodium
AbbVie Inc.
Divalproex Sodium
AbbVie Inc.
Divalproex Sodium
AbbVie Inc.
Divalproex Sodium
AbbVie Inc.
Unit Dose Solutions, Inc.
Major Pharmaceuticals
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.